Table:
begin	end	state
1	28	cytoplasmic
29	50	transmembrane
51	67	non-cytoplasmic
68	89	transmembrane
90	100	cytoplasmic
101	119	transmembrane
120	125	non-cytoplasmic
126	147	transmembrane
148	169	cytoplasmic
170	193	transmembrane
194	200	non-cytoplasmic
201	220	transmembrane
221	250	cytoplasmic
251	271	transmembrane
272	291	non-cytoplasmic
292	309	transmembrane
310	319	cytoplasmic
320	340	transmembrane
341	345	non-cytoplasmic
346	367	transmembrane
368	377	cytoplasmic
378	400	transmembrane
401	411	non-cytoplasmic
412	430	transmembrane
431	446	cytoplasmic

Input:
>WP_004686360.1 NCBI__GCF_000022745.1:WP_004686360.1
MNNAGMHVDANGEVEAPHDAHDTRRRVYAIVASASGNLVEWYDFYVYSFGALYFASQFFP
AEDQTSQLLNAAAIFAAGFLMRPIGGWLFGRIADKLGRRLSMLVSVTMMCFGSFAIAILP
TYETIGVLAPFLLLVVRLVQGLSVGGEYGTTATYMSEVALAGRRGFFSSFQYVTLIGGQL
LAVLVIVVLQFLLTSEQLHSWGWRIPFAIGGLAAIVALYLRRTLHETSTEKTRGNKAAGS
FSNIWKNHRKAFLVVVGFTAGGSLSFYTFTTYMQKYLVNTAGMSKETASETMTFVLLVFM
LMQPLFGALSDKVGRKTMMMGFGGISILTTIPLMTVIGSVQSSTWAFIYIVIALAVVSMY
TSVSGIVKAELFPAEVRALGVGFSYAIANALFGGTAEYVALWFKKQGMESGFFWYVTAIM
VVVFIVSLLMPNPREHGYLQGHGSDD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server